Daniel Howrigan, PhD
Daniel is a post-doctoral fellow at ATGU and the Broad Institute of Harvard and MIT. He is advised by Dr. Benjamin Neale, and his research is broadly focused on genome-wide analyses of complex psychiatric disease. Daniel recieved his PhD in 2012 from the University of Colorado, Boulder (supervised by Dr. Matthew Keller and Dr. Matthew McQueen). During his time in Colorado, his research investigated the detection of autozygosity (a genetic signature of inbreeding) in genome-wide SNP arrays and their impact on IQ and Schizophrenia liability. Currently, his work is focused on whole-exome sequence analysis to identify de novo variants in sporadic cases of Schizophrenia, and is in close collaboration with analyses underway in the Psychiatric Genetics Consortium (PGC) and ADHD exome chip project.